AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32698775 — intervention group
Group type: EXPERIMENTAL
Intervention: Large tidal volumes and high driving pressure
Number of subjects: 302
Study 32698814 — intervention group
Group type: EXPERIMENTAL
Intervention: CARE's Community Score Card© (CSC) process
Number of subjects: 0
Study 32699021 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal brachytherapy or no adjuvant treatment
Number of subjects: 182
Study 32699163 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group screening for haemoglobinopathies
Number of subjects: 855
Study 32699163 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of screening in prenatal care
Number of subjects: 855
Study 32699163 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendation for screening among high-risk pregnant women
Number of subjects: 855
Study 32699163 — intervention group
Group type: EXPERIMENTAL
Intervention: Examination of adverse pregnancy outcomes
Number of subjects: 855
Study 32699166 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonates with COVID-19 and SARS-CoV-2 infection
Number of subjects: 0
Study 32699166 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonates exposed to SARS-CoV-2
Number of subjects: 0
Study 32699580 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS) applied circumferentially after anastomosis (2.5 mL of porcine FS)
Number of subjects: 57
Study 32699580 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 57
Study 32699642 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive Functioning for Enhancing Community-based Treatment for ASD (EFFECT for ASD)
Number of subjects: 0
Study 32699643 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) 1 g at the start and end of surgery
Number of subjects: 100
Study 32699643 — intervention group
Group type: COMPARATOR
Intervention: Placebo for TXA
Number of subjects: 100
Study 32699643 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rosuvastatin 40 mg before and 20 mg daily for 30 days after surgery
Number of subjects: 100
Study 32699643 — intervention group
Group type: COMPARATOR
Intervention: Placebo for rosuvastatin
Number of subjects: 100
Study 32699645 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral treatment for gambling
Number of subjects: 0
Study 32699648 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcome (PRO)-measures as a dialogue tool in patient-physician consultations
Number of subjects: 5
Study 32699648 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient involvement in research (PPI)
Number of subjects: 5
Study 32699648 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-creation in analysis
Number of subjects: 5
Study 32699908 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic septal rebound stretch (SRSsept)
Number of subjects: 200
Study 32699908 — intervention group
Group type: EXPERIMENTAL
Intervention: SRSsept
Number of subjects: 200
Study 32699908 — intervention group
Group type: EXPERIMENTAL
Intervention: SRSsept and ApRock
Number of subjects: 200
Study 32699926 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-Conserving Therapy (BCT) with whole-breast radiation
Number of subjects: 216
Study 32699926 — intervention group
Group type: EXPERIMENTAL
Intervention: BREAST-Q satisfaction score at 6 months post-radiation
Number of subjects: 216
Study 32699926 — intervention group
Group type: EXPERIMENTAL
Intervention: BREAST-Q satisfaction score at 3 years post-surgery
Number of subjects: 216
Study 32699996 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI measured fat fraction (FF)
Number of subjects: 33
Study 32700065 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg AG-221 oral dose
Number of subjects: 6
Study 32700114 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated osteoporosis care (IOC) programme
Number of subjects: 0
Study 32700114 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 0
Study 32700139 — intervention group
Group type: EXPERIMENTAL
Intervention: Cxbladder Monitor (low-probability result)
Number of subjects: 828
Study 32700139 — intervention group
Group type: EXPERIMENTAL
Intervention: Cxbladder Monitor (elevated-probability result)
Number of subjects: 828
Study 32700139 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall management with Cxbladder Monitor
Number of subjects: 828
Study 32700139 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall procedures ordered for low-probability patients
Number of subjects: 828
Study 32700139 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive procedures for elevated-probability patients
Number of subjects: 828
Study 32700140 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic ectoine mouthwash
Number of subjects: 45
Study 32700140 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ectoine mouthwash
Number of subjects: 45
Study 32700140 — intervention group
Group type: COMPARATOR
Intervention: Calcium phosphate mouthwash
Number of subjects: 45
Study 32700140 — intervention group
Group type: EXPERIMENTAL
Intervention: Ectoine mouthwash (both prophylactic and active)
Number of subjects: 45
Study 32700140 — intervention group
Group type: EXPERIMENTAL
Intervention: Ectoine mouthwash
Number of subjects: 45
Study 32700260 — intervention group
Group type: EXPERIMENTAL
Intervention: MenB-FHbp vaccine
Number of subjects: 3989
Study 32700260 — intervention group
Group type: COMPARATOR
Intervention: Control (hepatitis A virus vaccine/saline or saline)
Number of subjects: 3989
Study 32700543 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand high-sensitivity troponin I (Abbott Architect) measurements using fresh blood samples
Number of subjects: 937
Study 32700543 — intervention group
Group type: COMPARATOR
Intervention: Batch-wise high-sensitivity troponin T (Roche) measurements using frozen blood samples
Number of subjects: 937
Study 32700543 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall on-demand and batch-wise measurements of high-sensitivity troponin
Number of subjects: 937
Study 32700543 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid diagnostic algorithms
Number of subjects: 937
Study 32700765 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with hormone receptor (HR) positive metastases
Number of subjects: 3295
Study 32700765 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ER conversion from negative to positive
Number of subjects: 3295
Study 32700765 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with PR remained positive
Number of subjects: 3295
Study 32700765 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with PR conversion
Number of subjects: 3295
Study 32701364 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-Fixation Atrial Leads
Number of subjects: 0
Study 32701364 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32701367 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 32701411 — intervention group
Group type: EXPERIMENTAL
Intervention: CD30.CAR-Ts after lymphodepletion with fludarabine-based regimen
Number of subjects: 41
Study 32701541 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroid injections (ESI) for leg pain
Number of subjects: 318
Study 32701541 — intervention group
Group type: EXPERIMENTAL
Intervention: Facet interventions for low back pain
Number of subjects: 318
Study 32701541 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacroiliac joint (SIJ) injections
Number of subjects: 318
Study 32701811 — intervention group
Group type: EXPERIMENTAL
Intervention: F-fluciclovine PET/CT
Number of subjects: 1
Study 32701811 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy of the mediastinal mass
Number of subjects: 1
Study 32701818 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPI-46 PET/CT
Number of subjects: 1
Study 32701818 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-FDG PET/CT
Number of subjects: 1
Study 32701818 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted Ivor-Lewis esophagectomy
Number of subjects: 1
Study 32702087 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial injury diagnosed according to the peak troponin I in relation to the upper reference limit (URL, 99th centile) using Abbott Architect troponin I assay.
Number of subjects: 0
Study 32702087 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystem, multimodality imaging including multiparametric, stress perfusion, cardiovascular magnetic resonance imaging, and computed tomography coronary angiography at 28 days post-discharge.
Number of subjects: 0
Study 32702120 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted metagenomics using strand-specific libraries with target enrichment
Number of subjects: 17
Study 32702120 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV-A
Number of subjects: 17
Study 32702120 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV-B
Number of subjects: 17
Study 32702156 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular interventions (angioplasty 95, stenting 26)
Number of subjects: 101
Study 32702156 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular interventions
Number of subjects: 101
Study 32702156 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-interventional dual antiplatelet therapy (DAPT)
Number of subjects: 101
Study 32702156 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent surgery
Number of subjects: 101
Study 32702156 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical failure
Number of subjects: 101
Study 32702156 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 101
Study 32702156 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinopathy secondary to hypertension
Number of subjects: 101
Study 32702156 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery hypertension (PAH)
Number of subjects: 101
Study 32702156 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions on mid-aorta stenosis (MAS) or renal artery stenosis (RAS)
Number of subjects: 101
Study 32702336 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with TBI
Number of subjects: 13138
Study 32702410 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (survivors of OHCA with GCS ≥12)
Number of subjects: 139
Study 32702570 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab 10 mg/kg every 2 weeks
Number of subjects: 444
Study 32702685 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized gradient field function
Number of subjects: 0
Study 32702685 — intervention group
Group type: COMPARATOR
Intervention: Cross correlation, mutual information, and gradient methods
Number of subjects: 0
Study 32702810 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue imaging using automatic tongue diagnosis system
Number of subjects: 67
Study 32702903 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer-free sirolimus-eluting stent implantations in dialysis patients
Number of subjects: 6791
Study 32702903 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer-free sirolimus-eluting stent implantations in CKD patients
Number of subjects: 6791
Study 32702903 — intervention group
Group type: COMPARATOR
Intervention: Polymer-free sirolimus-eluting stent implantations in patients with normal renal function (NRF)
Number of subjects: 6791
Study 32703167 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear implant rehabilitation
Number of subjects: 100
Study 32703186 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary habits and their association with cognitive function, gut microbiota composition, and brain measures.
Number of subjects: 683
Study 32703186 — intervention group
Group type: COMPARATOR
Intervention: Clinical evaluation including neurological examination and MRI scanning for individuals with confirmed Mild Cognitive Impairment (MCI).
Number of subjects: 683
Study 32703235 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-impregnated gel dressing (gel-dress)
Number of subjects: 3483
Study 32703235 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-impregnated gel dressing (gel-dress) with CHG skin antisepsis
Number of subjects: 3483
Study 32703509 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorine-18 flurpiridaz PET
Number of subjects: 795
Study 32703509 — intervention group
Group type: COMPARATOR
Intervention: Technetium-99m-labeled SPECT
Number of subjects: 795
Study 32703550 — intervention group
Group type: EXPERIMENTAL
Intervention: QoR-15K (postoperative)
Number of subjects: 193
Study 32703550 — intervention group
Group type: EXPERIMENTAL
Intervention: QoR-15K (preoperative)
Number of subjects: 193
Study 32703556 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramural needle ablation at IES sites
Number of subjects: 26
Study 32703590 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk model incorporating clinical, angiographic, and physiological parameters
Number of subjects: 2200
Study 32703590 — intervention group
Group type: COMPARATOR
Intervention: Risk model with clinical risk factors alone
Number of subjects: 2200
Study 32703590 — intervention group
Group type: COMPARATOR
Intervention: Risk model with clinical risk factors and angiographic parameters
Number of subjects: 2200
Study 32703590 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk model incorporating clinical, angiographic, and physiological predictors
Number of subjects: 2200
Study 32703690 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Secure (FS)
Number of subjects: 579
Study 32703690 — intervention group
Group type: COMPARATOR
Intervention: Low Food Security (low FS)
Number of subjects: 579
Study 32703690 — intervention group
Group type: COMPARATOR
Intervention: Very Low Food Security (very low FS)
Number of subjects: 579
Study 32704173 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg daily and Lenalidomide 25 mg daily
Number of subjects: 44
Study 32704173 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus and Lenalidomide combination
Number of subjects: 44
Study 32704173 — intervention group
Group type: EXPERIMENTAL
Intervention: PD assessment
Number of subjects: 44
Study 32704381 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged strenuous exercise training
Number of subjects: 277
Study 32704381 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive data collection including anthropometry, resting electrocardiography, echocardiography, blood sampling, retinal vessel diameters, carotid sonography, and cardiopulmonary exercise testing
Number of subjects: 277
Study 32704557 — intervention group
Group type: EXPERIMENTAL
Intervention: THEMIS-like cohort (ticagrelor plus acetylsalicylic acid)
Number of subjects: 125830
Study 32704557 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD-T2D cohort (placebo plus acetylsalicylic acid)
Number of subjects: 125830
Study 32704557 — intervention group
Group type: COMPARATOR
Intervention: Both cohorts
Number of subjects: 125830
Study 32704557 — intervention group
Group type: EXPERIMENTAL
Intervention: THEMIS-like cohort
Number of subjects: 125830
Study 32704557 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD-T2D cohort
Number of subjects: 125830
Study 32705337 — intervention group
Group type: EXPERIMENTAL
Intervention: DMEK with easy unfolding and attachment (Group I)
Number of subjects: 169
Study 32705337 — intervention group
Group type: EXPERIMENTAL
Intervention: DMEK with moderate difficulty (Group II)
Number of subjects: 169
Study 32705337 — intervention group
Group type: EXPERIMENTAL
Intervention: DMEK with high difficulty (Group III)
Number of subjects: 169
Study 32705337 — intervention group
Group type: EXPERIMENTAL
Intervention: DMEK with very high difficulty (Group IV)
Number of subjects: 169
Study 32705923 — intervention group
Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin (pola) + bendamustine-rituximab (BR) at 1.8 mg/kg pola, every 3 weeks for six cycles
Number of subjects: 0
Study 32705923 — intervention group
Group type: COMPARATOR
Intervention: Polatuzumab vedotin (pola)
Number of subjects: 0
Study 32705923 — intervention group
Group type: COMPARATOR
Intervention: Bendamustine-obinutuzumab (BG)
Number of subjects: 0
Study 32706437 — intervention group
Group type: EXPERIMENTAL
Intervention: C-SSRS (Columbia-Suicide Severity Rating Scale) during ED visit
Number of subjects: 1376
Study 32706437 — intervention group
Group type: EXPERIMENTAL
Intervention: History of prior SA as measured by C-SSRS
Number of subjects: 1376
Study 32706533 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial strains obtained from children with EED
Number of subjects: 110
Study 32706533 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota from children with EED
Number of subjects: 110
Study 32706533 — intervention group
Group type: EXPERIMENTAL
Intervention: Gnotobiotic mice colonized with cultured duodenal strains from children with EED
Number of subjects: 110
Study 32706636 — intervention group
Group type: EXPERIMENTAL
Intervention: CTS5 high-risk group
Number of subjects: 7486
Study 32706636 — intervention group
Group type: EXPERIMENTAL
Intervention: CTS5 intermediate-risk group
Number of subjects: 7486
Study 32706636 — intervention group
Group type: EXPERIMENTAL
Intervention: CTS5 low-risk group
Number of subjects: 7486
Study 32706636 — intervention group
Group type: EXPERIMENTAL
Intervention: CTS5 high-risk patients
Number of subjects: 7486
Study 32706652 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth group
Number of subjects: 26
Study 32706652 — intervention group
Group type: EXPERIMENTAL
Intervention: paper diary group
Number of subjects: 26
Study 32706652 — intervention group
Group type: COMPARATOR
Intervention: control group (standard of care)
Number of subjects: 26
Study 32706656 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message survey
Number of subjects: 17
Study 32706702 — intervention group
Group type: EXPERIMENTAL
Intervention: mRehab (smartphone app with 3D printed objects)
Number of subjects: 16
Study 32706719 — intervention group
Group type: COMPARATOR
Intervention: Health education podcast app (listened to ~60 min/week for 12 weeks)
Number of subjects: 96
Study 32706719 — intervention group
Group type: COMPARATOR
Intervention: Health education podcast app
Number of subjects: 96
Study 32706720 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathe (ICBT with ad hoc telephone and email support)
Number of subjects: 94
Study 32706720 — intervention group
Group type: COMPARATOR
Intervention: Control group (static webpage listing anxiety resources)
Number of subjects: 94
Study 32706891 — intervention group
Group type: EXPERIMENTAL
Intervention: Treosulfan-based conditioning (TREO, fludarabine, 2 Gy total-body irradiation)
Number of subjects: 130
Study 32707340 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatic steatosis
Number of subjects: 3756
Study 32707340 — intervention group
Group type: COMPARATOR
Intervention: No hepatic steatosis
Number of subjects: 3756
Study 32709042 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive lobular carcinoma (ILC)
Number of subjects: 0
Study 32709042 — intervention group
Group type: COMPARATOR
Intervention: Invasive ductal carcinoma of no special type (NST)
Number of subjects: 0
Study 32709218 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-stage ADPKD treatment options (specific treatment details not provided)
Number of subjects: 0
Study 32709218 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete Choice Experiment (DCE)
Number of subjects: 0
Study 32709235 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and post-bronchodilator spirometry tests
Number of subjects: 220
Study 32709235 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted American Thoracic Society Epidemiological Questionnaire
Number of subjects: 220
Study 32709235 — intervention group
Group type: EXPERIMENTAL
Intervention: Air quality measures assessment (particulate matter, carbon monoxide, carbon dioxide, humidity)
Number of subjects: 220
Study 32709235 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care utilization data from electronic medical records
Number of subjects: 220
Study 32709249 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized quality improvement based on the Computer Analysing system (CASE)
Number of subjects: 30
Study 32709249 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention stage
Number of subjects: 30
Study 32709249 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention stage (with education)
Number of subjects: 30
Study 32709249 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention stage (without education)
Number of subjects: 30
Study 32709381 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine transplantation
Number of subjects: 9
Study 32709653 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic analysis of selected plasma and transcriptomic biomarkers (procalcitonin, IL-6, IL-10, IP10) at delivery and every other week for occurrence of sepsis.
Number of subjects: 580
Study 32710011 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody-radionuclide conjugate targeting CD45
Number of subjects: 0
Study 32710245 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dose HAB 720
Number of subjects: 1
Study 32710657 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education for families of infants
Number of subjects: 14241
Study 32710922 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab monotherapy
Number of subjects: 0
Study 32711035 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver stiffness (LS) assessment
Number of subjects: 129
Study 32711035 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence
Number of subjects: 129
Study 32711035 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver stiffness (LS) of abstinent subjects
Number of subjects: 129
Study 32711035 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP™ values
Number of subjects: 129
Study 32711035 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic median-term follow-up
Number of subjects: 129
Study 32711035 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver stiffness (LS)
Number of subjects: 129
Study 32711479 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly CKD patients
Number of subjects: 0
Study 32711479 — intervention group
Group type: COMPARATOR
Intervention: Matched control group with normal kidney function (estimated glomerular filtration rate ≥ 60 ml/min/1.73m²)
Number of subjects: 0
Study 32711502 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable single 8-0 polypropylene suture for scleral fixation without conjunctival dissection
Number of subjects: 27
Study 32711502 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative complications
Number of subjects: 27